FDA Commissioner Makary Warns of US Lagging Behind China in Biotech Amid Proposed Budget and Reforms on April 07, 2026 China Clinical Trials Drug Development Marty Makary Trump administration United States Food and Drug Administration user fees +
Makary Proposes Higher FDA User Fees for Non-US Phase I Trials to Counter China Biotech on January 20, 2026 Americas China Makary Phase I Clinical Trials United States Food and Drug Administration user fees +
Despite Government Shutdown, Companies Still Plan to Submit FDA Applications on October 03, 2025 AbbVie Amgen Application procedure biology (field) drug applications funding lapse government J&J Myers Squibb Pfizer pharmaceutical delays shutdown United States Food and Drug Administration user fees +
US Government Shutdown Threatens to Stress an Already Depleted FDA on October 01, 2025 delays Drug Approval federal funding Government Shutdown public health medicine (field) regulatory Staff Surgical aspects United States Food and Drug Administration user fees +
FDA Chief Calls for Lower User Fees as PDUFA VIII Negotiations Begin on July 15, 2025 Drug Approval fee structure Mediation PDUFA VIII regulatory policy United States Food and Drug Administration user fees +